Clinical features of psoriatic arthritis.
Kishimoto M, Deshpande GA, Fukuoka K, Kawakami T, Ikegaya N, Kawashima S, Komagata Y, Kaname S.
Best Pract Res Clin Rheumatol. 2021 Jun;35(2):101670. doi: 10.1016/j.berh.2021.101670. Epub 2021 Mar 17.
Arthritis mutilans.
Haddad A, Chandran V.
Curr Rheumatol Rep. 2013 Apr;15(4):321. doi: 10.1007/s11926-013-0321-7.
Psoriatic arthritis mutilans.
Samanta J, Chattopadhyay A, Sharma A.
QJM. 2020 Oct 1;113(10):765-766. doi: 10.1093/qjmed/hcaa029.
Psoriatic arthritis.
Gladman DD, Brockbank J.
Expert Opin Investig Drugs. 2000 Jul;9(7):1511-22. doi: 10.1517/13543784.9.7.1511.
Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans.
Wang S, Nikamo P, Laasonen L, Gudbjornsson B, Ejstrup L, Iversen L, Lindqvist U, Alm JJ, Eisfeldt J, Zheng X, Catrina SB, Taylan F, Vaz R, Ståhle M, Tapia-Paez I.
EMBO Mol Med. 2024 Mar;16(3):596-615. doi: 10.1038/s44321-024-00035-z. Epub 2024 Feb 20.
Juvenile psoriatic arthritis.
Ansell BM.
Baillieres Clin Rheumatol. 1994 May;8(2):317-32. doi: 10.1016/s0950-3579(94)80021-9.
Apremilast for the treatment of psoriatic arthritis.
Martin BC, Thomas LW, Dann FJ.
Dermatol Online J. 2017 Feb 15;23(2):13030/qt36n2k4jw.
[Psoriatic arthritis mutilans].
González-Nieto JA, López-Montes L, Gallego-García F, Tugues-Roure JM.
Rev Clin Esp. 2012 Nov;212(10):e87. doi: 10.1016/j.rce.2012.06.005. Epub 2012 Aug 4.
Treatment of refractory psoriatic arthritis.
Pioro MH, Cash JM.
Rheum Dis Clin North Am. 1995 Feb;21(1):129-49.
Psoriatic arthritis: a critical review.
Dhir V, Aggarwal A.
Clin Rev Allergy Immunol. 2013 Apr;44(2):141-8. doi: 10.1007/s12016-012-8302-6.
